Preparation for Medical and Surgical Procedures in Oncogeriatry.
PRIMECHO
1 other identifier
interventional
20
1 country
1
Brief Summary
Surgical management is one of the most frequently used interventions in the treatment of many cancers, but it can be associated with a high risk of postoperative complications. The maintenance and optimization of functional abilities before, during and after treatment are major for elderly cancer patients, as it is now well established that there is a link between the level of functional capacity and the occurrence of these complications. The scientific literature shows that the benefits of pre- and post-operative training programs, but these benefits only apply to a fraction of the patients adhering to the programs. The modalities of intervention (training load, follow-up, etc.) as well as patient involvement in these programs are major issues that need to be addressed to optimize their benefits. Individualizing pre-habilitation, on the basis of the management of the training load, and therefore objective fatigue, would enable better patient adherence to the program, and optimize its benefits. In this context, the PRIMECHO project aims to individualize pre-habilitation in order to improve functional of patients in the pre-habilitation or accelerated recovery after surgery phase. The aim is for the patient to be in optimum physical condition at the time of the intervention or treatment.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Nov 2024
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
May 23, 2024
CompletedFirst Posted
Study publicly available on registry
June 5, 2024
CompletedStudy Start
First participant enrolled
November 6, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 10, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
November 10, 2027
March 19, 2026
March 1, 2026
3 years
May 23, 2024
March 17, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Maximal walking distance to 6 -MWT
Metres walked during 6 minutes
at inclusion
Maximal walking distance to 6 -MWT
Metres walked during the test
at 4 weeks
Maximal walking distance to 6 -MWT
Metres walked during the test
at 8 weeks
Maximal walking distance to 6 -MWT
Metres walked during the test
at 16 weeks
Secondary Outcomes (3)
EORTC-QLQC30
at inclusion, 4 weeks, 8 weeks, 16 weeks
Fatigue scale (MFI-20)
at inclusion, 4 weeks, 8 weeks, 16 weeks
Internationnal Physiqual activity questionaire (IPAQ-short)
at inclusion, 4 weeks, 8 weeks, 16 weeks
Study Arms (1)
Personalized pre-habilitation program
EXPERIMENTALInterventions
Each patient will undergo 4 weeks of individualized pre-habilitation before surgery. Each session (1 session per day) will be carried out autonomously by the patient at home, via a dedicated application (Activiti Pro) installed on their tablet or smartphone.
Eligibility Criteria
You may qualify if:
- Patient aged 70 or over
- Cancer patient with planned surgery,
- Mini Mental State Examination score greater than or equal to 24 (performed in advance by the geriatrician),
- Patient affiliated to or benefiting from a social security insurance
- Signed free and informed consent.
You may not qualify if:
- Inability to walk or perform unsupervised exercises.
- Vulnerable people
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
CHU de Nice
Nice, France
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Rabia Boulahssass, MD
Centre Hospitalier Universitaire de Nice
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
May 23, 2024
First Posted
June 5, 2024
Study Start
November 6, 2024
Primary Completion (Estimated)
November 10, 2027
Study Completion (Estimated)
November 10, 2027
Last Updated
March 19, 2026
Record last verified: 2026-03